Combined effects of smoking and peripheral arterial disease on all-cause and cardiovascular disease mortality in a Chinese male cohort
|
|
- Marjorie Pearson
- 5 years ago
- Views:
Transcription
1 Combined effects of smoking and peripheral arterial disease on all-cause and cardiovascular disease mortality in a Chinese male cohort Yingyi Luo, MD, a,b Xiankai Li, MD, b Jue Li, MD, PhD, b Xiaoming Wang, MD, a Yongxia Qiao, MD, b Dayi Hu, MD, b Philip A. Merriam, MSPH, c and Yunsheng Ma, MD, PhD, c Shanghai, China; and Worcester, Mass Objective: Smoking is a major risk factor for peripheral arterial disease (PAD), and PAD is associated with all-cause and cardiovascular disease (CVD) mortality. The objective of this study was to determine the combined effects of smoking and PAD on all-cause and CVD mortality. Methods: A total of 1979 males 35 years of age or older were enrolled from eight university-affiliated hospitals in Beijing and Shanghai in 2004, with both smoking status and PAD diagnosis obtained, 1712 of them had complete follow-up data. Mortality data were obtained from all participants between December 2007 and February Cox proportional hazards models were used to evaluate relative risks (RRs) of all-cause mortality and CVD mortality among different groups. Results: At baseline, the average age of participants was years-old (SD 11.57), prevalence of PAD was 24.0% and 65.4% smoked cigarettes. During the 3-year follow-up, all-cause cumulative mortality rates were 27.9% (PAD/smoker), 26.3% (PAD/nonsmoker), 14.1% (no PAD/smoker), and 14.4% (no PAD/nonsmoker) (P <.001), and CVD cumulative mortality rates were 17.8%, 14.9%, 8.1%, and 7.3%, respectively (P <.001). Compared with the no PAD/nonsmoker subjects, adjusted RR from all-cause mortality in the groups of both PAD/smoker, PAD/nonsmoker, and no PAD/ smoker were 1.88 (95% confidence interval [CI], ), 1.37 (95% CI, ), and 1.08 (95% CI, ), respectively. The adjusted RR from CVD mortality was 2.12 (95% CI, ), 1.55 (95% CI, ), and 1.13 (95% CI, ), respectively. Conclusion: PAD is a major determinant of mortality. Smoking did not contribute to mortality in this study. Further research is needed. (J Vasc Surg 2010;51:673-8.) From the Shanghai Institute of Health Sciences, a Heart, Lung, and Blood Vessel Center, Tongji University School of Medicine, b and the Division of Preventive and Behavioral Medicine, Department of Medicine, University of Massachusetts Medical School. c Competition of interest: none. Reprint requests: Jue Li, MD, PhD, Tongji University School of Medicine, Heart, Lung, and Blood Vessel Research Center, 1239 Siping Road, Shanghai , China ( jueli59jp@yahoo.co.jp). The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest /$36.00 Copyright 2010 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery. doi: /j.jvs Peripheral arterial disease (PAD) is a clinical manifestation of the atherosclerotic process, which is associated with the increased prevalence of cardiovascular disease (CVD) and elevated CVD mortality. 1,2 Many studies have shown that PAD is a strong prospective predictor of CVD mortality and all-cause mortality, independent of other adjusted risk factors. 3-6 Up to 20% of elderly individuals have PAD upon noninvasive testing, 7-10 and is common in elderly Chinese people. 11 Because only a small percentage of these individuals are symptomatic, PAD is difficult to be recognized in primary care practice. 12,13 In China, He et al 11 showed that 43% of the PAD patients were asymptomatic and unaware of their condition. As a consequence, numerous studies have attempted to assist physicians in identifying individuals with the greatest risk of developing PAD. Such studies consistently identify smoking as a key risk factor. 14,15 Because smoking is also an important predictor of mortality, 16,17 it was hypothesized that the risk of death is higher in smoking patients with PAD than in nonsmoking patients with PAD. Except for a couple of 1-year studies that reported the relationship between PAD and mortality in Chinese patients, 18,19 this issue has not been researched extensively in China. The prevalence of smoking in China is as high as 59.3% in males whereas few females smoke. 20 Estimates from 1988 showed that China consumes 30% of all cigarettes worldwide (ie, 1.5 trillion cigarettes). 21 It has been predicted that in China alone, 50 million individuals currently under 20 years of age will ultimately die of tobaccorelated diseases. 22 The combined effect of smoking and PAD to all-cause and CVD mortality in Chinese male adults is not clear. Thus, the purposes of this study were to investigate the association between smoking and PAD, and the risk of all-cause and CVD mortality for smoking and nonsmoking Chinese males with and without PAD. MATERIALS AND METHODS Study subjects. The ankle brachial index (ABI) Cohort Study was designed in 2004 to investigate the risk factors of PAD and the relationship between ABI and 673
2 674 Luo et al JOURNAL OF VASCULAR SURGERY March 2010 mortality from all-cause and CVD. Subjects were recruited from the department of endocrinology or a cardiology in-patient clinic located in eight university-attached hospitals located in Beijing and Shanghai between July and November A total of 1979 male participants, 35 years or older who had complete baseline data, were entered in this study cohort. Follow-up visits were held between December 2007 and February Of the 1979 male participants, 1712 of them had complete follow-up data. This study was approved by the ethics committee of Tongji University and informed consent was obtained from each participant. Measurement of ankle and arm blood pressures. Doppler ultrasound scan (Nicolet Vascular, Elite 100R, Madison, Wisc) was used to measure systolic pressure on bilateral brachial, posterior tibial, and dorsal pedal arteries in the supine position after a 5-minute rest. The occluding cuffs ( cm) were applied just above the malleoli to measure ankle pressure. The Doppler scan probe was used at a frequency of 5 MHz. Right and left ABIs were calculated by the highest pressure on the dorsal or posterior tibial arteries on the right and left sides, respectively, and by the highest brachial pressure on either side. Diagnosis of peripheral arterial disease. The American College of Cardiology and the American Heart Association (ACC/AHA) guidelines have recommended ABI 0.90 as the criterion for the diagnosis of PAD. 23 Our study adopted this recommendation for participants with an ABI 0.90 in either leg as PAD, whereas participants with an ABI from 0.91 to 1.40 were considered not to have PAD. Classification of smoking behavior. Participants were asked to describe their smoking habits in the 2004 baseline questionnaire, including the number of cigarettes smoked per day and the duration of cigarette smoking. Smoker refers to the participants who reported smoking cigarettes or had smoked other tobacco products at least once a day for 1 year or more. 24 The dose of smoking was further classified by the average number of cigarettes smoked per day (0, 1-15, and 16 cigarettes per day) and by the cumulative number of cigarettes ever smoked (0, 365, 100,000, 200,000, 300,000, 400,000 cigarettes). Diagnosis of diabetes, hypertension, chronic kidney disease, and coronary heart disease. Diabetes was defined as having a fasting glucose 7 mmol/l, reported use of hypoglycemic medication, or reported diabetes at the baseline examination; hypertension: a systolic blood pressure (SBP) 140 mm Hg and/or diastolic blood pressure (DBP) 90 mm Hg, reported use of hypertensive medications, or reported hypertension history at the baseline examination; chronic kidney disease (CKD): an estimated glomerular filtration rate (egfr) 60 ml/minute per 1.73 m 2 or reported CKD history at the baseline examination; and coronary heart disease (CHD): confirmed by coronariography, a previous myocardial infarction, or surgery or coronary revascularization. All these diagnoses for participants were reviewed by study physicians. Table I. The proportion of cause of death for male participants of ABI cohort study in China, 3-years followup (n 1712) Cause of death n Proportion (%) Coronary heart disease Ischemic stroke Hemorrhagic stroke Other cardiovascular disease Others Total ABI, Ankle brachial index. Identification of all-cause and cardiovascular disease mortality. Death was confirmed from hospital records or by contact with participants and their families. Cause of death was investigated using medical records and key informant interviews. The CVD mortality was estimated according to the International Classification of Diseases 10 (ICD-10). All materials were reviewed independently and blindly by a physician to confirm the cause of death. Statistical analysis. Data were analyzed using the software program SPSS 13.0 (SPSS Inc, Chicago, Ill). Continuous variables were expressed as the mean SD, and categoric variables as a percentage. Independent samples t test and the 2 test were used to compare continuous and categoric variables, respectively. The cumulative mortality rates from all-cause and CVD were calculated by different groups. Survival analysis based on Kaplan-Meier curves and log-rank tests were used to compare survival rates in different smoker/pad groups. The relative risks of death from all-cause and CVD were adjusted for potential confounders including age, systolic blood pressure (SBP), body mass index (BMI), diabetes, hypertension, stroke, coronary heart disease, and chronic kidney disease using Cox proportional regression models. RESULTS There were 1712 male participants whose baseline data and follow-up data was available. Among them, 411 participants (24.0%) were in the low-abi group and diagnosed with PAD, with the remainder in the normal-abi group. According to our criterion described above, the prevalence of PAD was 24.0% in this cohort. The prevalence of smoking was 65.4%. During a mean follow-up time of months, 267 (13.5%) of them were lost to follow-up because of changing telephone numbers and family addresses. There is no significant difference in the smoking rates and PAD prevalence between subjects with and without follow-up data. Thus, among the 1712 participants who have complete follow-up data, 298 of them died, with 172 attributed to CVD. The 3-year cumulative mortality rate was 17.4%. The detailed cause of death proportions are shown in Table I.
3 JOURNAL OF VASCULAR SURGERY Volume 51, Number 3 Luo et al 675 Table II. Baseline characteristics for male participants with and without PAD (n 1712) Groups Baseline Characteristics With PAD n 411 Without PAD n 1301 P values Age BMI (kg/m 2 ) SBP (mm Hg) DBP (mm Hg) TC (mmol/l) TG (mmol/l) LDL-C (mmol/l) HDL-C (mmol/l) FPG (mmol/l) Diabetes (%) Dislipidemia (%) Stroke (%) Hypertension (%) Coronary heart disease (%) Chronic kidney disease (%) Smoking history (%) PAD, Peripheral arterial disease; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol. Data are means for continuous variables and percents for categorical variables. Comparison of baseline characteristics between groups with and without PAD. As shown in Table II, participants with PAD were older and had a lower BMI, higher SBP, and had a higher rate of diabetes, hypertension, stroke, coronary heart disease, and a history of smoking as compared with those without PAD at baseline. Relationship of smoking and peripheral arterial disease. The prevalence of PAD in smokers and nonsmokers was 26.5% and 19.3%, respectively (P.001). When the dose of smoking was classified into three groups by the number of cigarettes smoked per day (0, 1-15, and 16 cigarettes per day), the prevalence of PAD is 19.3%, 27.5%, and 25.8%, respectively, in each group (P.003). Participants who smoked 1-15 cigarettes per day had the highest PAD prevalence. When the dose of smoking was classified into six groups by cumulative number of cigarettes ever smoked (0, 365, 100,000, 200,000, 300,000, 400,000 cigarettes), the prevalence of PAD is 19.3%, 24.0%, 23.1%, 24.7%, 39.2%, and 31.1%, respectively (P.001). The prevalence of PAD increased sharply when the cumulative number of cigarettes was 300,000. All-cause and cardiovascular disease mortality in different smoking/peripheral arterial disease groups. Fig 1 shows the all-cause and CVD mortality in the four different smoking/nonsmoking and PAD/no PAD groups. The 1712 male participants who had complete follow-up data were classified into four groups. A total of 297 of them were both smokers and had PAD, 114 had PAD only, 823 were smokers only, and 478 neither smoked nor had PAD. Fig 1. All-cause and cardiovascular disease (CVD) mortality according to peripheral arterial disease (PAD)/smoker group, the ankle-brachial index (ABI) Cohort Study, 3-years follow-up, (n 1712). The cumulative all-cause mortality was 27.9%, 26.3%, 14.1%, and 14.4%, respectively (P.001), and CVD mortality was 17.8%, 14.9%, 8.1%, and 7.3%, respectively (P.001). Survival analysis for different smoking/peripheral arterial disease groups. Kaplan-Meier curves in Fig 2, a and b show the survival distribution of the four groups for all-cause and CVD mortality, respectively. The survival rate for both PAD and smoker group was significantly lower than that for the no PAD/nonsmoker group for both all-cause and CVD mortality (log-rank: P.001). We compared the survival rates in smokers vs nonsmokers within the PAD cohort. There is no significant difference between the two groups (P.41). Mortality risks according to different smoking/ peripheral arterial disease groups. The four groups were examined in relation to mortality in Cox regression models that adjusted for age, BMI, SBP, history of diabetes, hypertension, stroke, CHD, and CKD. Compared with the group of neither PAD/smoker, the adjusted relative risk (RR) from all-cause mortality in the PAD/smoker group, PAD/nonsmoker group, and no PAD/smoker were 1.88 (95% CI, ), 1.37 (95% CI, ), and 1.08 (95% CI, ), respectively. The adjusted RR from CVD mortality was 2.12 (95% CI, ), 1.55 (95% CI, ), and 1.13 (95% CI, ), respectively. DISCUSSION In this study, PAD prevalence was 24.0% and 65.4% of participants who smoked cigarettes in a Chinese male population. Of all the risk factors of PAD, smoking is one of the most important. Two studies have shown that cigarette smoking can result in a sevenfold increase in the risk of PAD. 25,26 In this study, the baseline characteristics are compared in Table II. The smoking rate in participants with PAD was significantly higher than that in participants without PAD. The prevalence of PAD in smokers was higher than that of nonsmokers (26.5% vs 19.3%; P.001). To
4 676 Luo et al JOURNAL OF VASCULAR SURGERY March 2010 a b Fig 2. a, Kaplan-Meier curves for subjects of peripheral arterial disease (PAD)/smoker groups from all-cause mortality, the ankle-brachial index (ABI) Cohort Study, 3-years follow-up. b, Kaplan-Meier curves for subjects of PAD/smoker groups from CVD mortality, the ABI Cohort Study, 3-years follow-up. assess the risk of PAD according to the dose of smoking, subsequent analysis was performed on subjects grouped according to their cigarettes smoked per day, and lifetime cumulative values. The prevalence of PAD increased with the cumulative number of cigarettes ever smoked, especially when the cumulative number is 300,000 cigarettes. Therefore, to stop smoking is an important way to decrease the PAD prevalence in China s high-risk male population. Smoking is related to mortality in many cohort studies. 16,27,28 A prospective male cohort study has shown that cigarette smoking was an important predictor of risk of mortality in men from Shanghai, and 21% of all-cause mortality could be attributed to cigarette smoking. 16 PAD is also related to mortality. 18 A cardiovascular medicine review about the relationship between PAD and mortality by Golomb et al 3 has shown that most studies demon-
5 JOURNAL OF VASCULAR SURGERY Volume 51, Number 3 Luo et al 677 strated PAD can powerfully predict overall mortality in men and women. This has also been shown in community cohorts, 10,29 medical-based cohorts, 30,31 and in a population at heightened CVD risk. 32 The RR ranged from 1.2 to While this issue is seldom discussed in Asian populations, the combined effect of smoking and PAD to all-cause and CVD mortality in individuals is not clear. Participants were further classified into four groups in this 3-year cohort study; the all-cause mortality in both PAD/smoker was twice that of the no PAD/nonsmoker group, and also higher than in the no PAD/smoker and the only PAD/ nonsmoker group. The CVD mortality in PAD/smoker was nearly three times that of the no PAD/nonsmoker group, and also higher than the no PAD/smoker and PAD/nonsmoker groups. It is possible that smoking will result in PAD, and then increase mortality, especially the mortality attributed to CVD. It is also possible that there is a combined effect of smoking and PAD to all-cause and CVD mortality. In this study, the participants in the PAD/smoker group had the lowest survival rate from survival analysis based on Kaplan-Meier curves. However, the survival rate for nonsmokers is not statistically significantly higher than smokers within the PAD cohort (log-rank, P.41). Although this is counter-intuitive and probably a type 2 error, further investigation is needed. The adjusted RRs of the PAD/smoker group from all-cause and CVD mortality were about twice that of no PAD/smoker or PAD/nonsmoker group, and also higher in the no PAD/smoker and PAD/nonsmoker groups. Thus if a male has a smoking habit and at the same time has PAD, he will be at the highest fatality risk, especially fatality due to CVD. It is hypothesized that atherosclerosis is aggravated because of smoking, which makes mortality, especially CVD mortality increase. Therefore, our suggestion is that male PAD patients should avoid smoking and those who smoke should stop smoking. We suggest that the Chinese government should spend more resources to deal with smoking-related diseases. This is the first study of a large cohort between PAD and mortality in China. Although the subjects are high-risk male participants, it really indicated a combined effect of smoking and PAD to all-cause and CVD mortality. Because the patients came from not only urban but also rural areas, the result will hold for all of the country including rural areas. The relationship between PAD and mortality in the general Chinese population should be considered in the future. A potential limitation of our study is the relatively brief duration of follow-up. Further studies should investigate the pathophysiologic mechanisms in which PAD, combined with a smoking habit, may result in all-cause and CVD mortality. In conclusion, our study analyzed the relationship between smoking and PAD and the risk of all-cause and CVD mortality for males with and without PAD who did and did not smoke, results suggest that PAD is a major determinant of mortality, whereas smoking did not contribute to mortality in this study, further research is needed. This study was financially supported by Shanghai Educational Development Foundation (China). AUTHOR CONTRIBUTIONS Conception and design: YL, XL, JL Analysis and interpretation: YL, XL, JL, XW, YM Data collection: YL, XW, YQ Writing the article: YL, YQ Critical revision of the article: XL, JL, XW, YQ, DH, PM, YM Final approval of the article: YL, XL, JL, XW, YQ, DH, PM, YM Statistical analysis: XL, JL, YM Obtained funding: JL, DH Overall responsibility: JL REFERENCES 1. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001;344: Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 2002;143: Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation 2006;114: Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, Howard BV. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004;109: Leibson CL, Ransom JE, Olson W, Zimmerman BR, O Fallon WM, Palumbo PJ. Peripheral arterial disease, diabetes, and mortality. Diabetes Care 2004;27: Sutton-Tyrrell K, Venkitachalam L, Kanaya AM, Boudreau R, Harris T, Thompson T, et al. Relationship of ankle blood pressures to cardiovascular events in older adults. Stroke 2008;39: Novo S. Classification, epidemiology, risk factors, and natural history of peripheral arterial disease. Diabetes Obes Metab 2002;4 Suppl 2:S Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol 1998;18: Stoffers HE, Rinkens PE, Kester AD, Kaiser V, Knottnerus JA. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol 1996;25: Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, Wolfson SK. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993;88: He Y, Jiang Y, Wang J, Fan L, Li X, Hu FB. Prevalence of peripheral arterial disease and its association with smoking in a population-based study in Beijing, China. J Vasc Surg 2006;44: Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286: McDermott MM, Kerwin DR, Liu K, Martin GJ, O Brien E, Kaplan H, Greenland P. Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice. J Gen Intern Med 2001;16: Aronow WS. Peripheral arterial disease in the elderly. Clin Interv Aging 2007;2: Sritara P, Sritara C, Woodward M, Wangsuphachart S, Barzi F, Hengprasith B, Yipintsoi T. Prevalence and risk factors of peripheral arterial disease in a selected Thai population. Angiology 2007;58: Yuan JM, Ross RK, Wang XL, Gao YT, Henderson BE, Yu MC. Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study. JAMA 1996;275:
6 678 Luo et al JOURNAL OF VASCULAR SURGERY March Kelly TN, Gu D, Chen J, Huang JF, Chen JC, Duan X, et al. Cigarette smoking and risk of stroke in the chinese adult population. Stroke 2008;39: Luo YY, Li J, Xin Y, Zheng LQ, Yu JM, Hu DY. Risk factors of peripheral arterial disease and relationship between low ankle brachial index and mortality from all-cause and cardiovascular disease in Chinese patients with hypertension. J Hum Hypertens 2007;21: Xu Y, Li J, Luo Y, Wu Y, Zheng L, Yu J, et al. The association between ankle-brachial index and cardiovascular or all-cause mortality in metabolic syndrome of elderly Chinese. Hypertens Res 2007;30: Ministry of Public Health. Smoking prevalence rate in China. P.R. China Tobacco. Cigarette sales are on the up. Tobacco Sept, Peto R. Future mortality from tobacco in China. Paper presented at: Shangai Symposium on Smoking and Health; November, 1987; Shangai, China. 23. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006;113: e WHO. Arterial hypertension report of a WHO expert committee Geneva, 1984, WHO. 25. Heliövaara M, Karvonen MJ, Vilhunen R, Punsar S. Smoking, carbon monoxide, and atherosclerotic diseases. Br Med J 1978;1: Hughson WG, Mann JI, Tibbs DJ, Woods HF, Walton I. Intermittent claudication: factors determining outcome. Br Med J 1978;1: Jacobs DR Jr, Adachi H, Mulder I, Kromhout D, Menotti A, Nissinen A, Blackburn H. Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study. Arch Intern Med 1999;159: Pham TM, Fujino Y, Ide R, Shirane K, Tokui N, Kubo T, et al. Mortality attributable to cigarette smoking in a cohort study in Japan. Eur J Epidemiol 2007;22: Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326: Leng GC, Fowkes FG, Lee AJ, Dunbar J, Housley E, Ruckley CV. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 1996;313: Behar S, Zion M, Reicher-Reiss H, Kaplinsky E, Goldbourt U. Shortand long-term prognosis of patients with a first acute myocardial infarction with concomitant peripheral vascular disease. SPRINT Study Group. Am J Med 1994;96: Ogren M, Hedblad B, Engström G, Janzon L. Prevalence and prognostic significance of asymptomatic peripheral arterial disease in 68- year-old men with diabetes. Results from the population study Men born in 1914 from Malmö, Sweden. Eur J Vasc Endovasc Surg 2005;29: Submitted Jul 16, 2009; accepted Sep 12, 2009.
Ankle Brachial Index as a Marker of Atherosclerosis in Chinese Patients with High Cardiovascular Risk
23 Original Article Hypertens Res Vol.29 (2006) No.1 p.23-28 Ankle Brachial Index as a Marker of Atherosclerosis in Chinese Patients with High Cardiovascular Risk Buaijiaer HASIMU 1), Jue LI 1), Tomohiro
More informationPrevalence of peripheral arterial disease and its association with smoking in a population-based study in Beijing, China
of peripheral arterial disease and its association with smoking in a population-based study in Beijing, China Yao He, MD, PhD, a,b Yong Jiang, MD, a Jie Wang, MD, PhD, c Li Fan, MD, d XiaoYing Li, MD,
More informationSensitivity and Specificity of Ankle-Brachial Index for Detecting Angiographic Stenosis of Peripheral Arteries
Circ J 2008; 72: 605 610 Sensitivity and Specificity of Ankle-Brachial Index for Detecting Angiographic Stenosis of Peripheral Arteries Xiaoming Guo, MD ; Jue Li, MD ; Wenyue Pang, MD*; Mingzhong Zhao,
More informationPrognostic Significance of Declining Ankle-brachial Index Values in Patients with Suspected or Known Peripheral Arterial Disease
Eur J Vasc Endovasc Surg 34, 206e213 (2007) doi:10.1016/j.ejvs.2007.02.018, available online at http://www.sciencedirect.com on Prognostic Significance of Declining Ankle-brachial Index Values in Patients
More informationIs the Ankle-Brachial Index a Useful Screening Test for Subclinical Atherosclerosis in Asymptomatic, Middle-Aged Adults?
Is the Ankle-Brachial Index a Useful Screening Test for Subclinical Atherosclerosis in Asymptomatic, Middle-Aged Adults? Rachael A. Wyman, MD; Jon G. Keevil, MD; Kjersten L. Busse, RN, MSN; Susan E. Aeschlimann,
More informationAsymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study
Journal of Clinical Epidemiology 57 (2004) 294 300 Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study J.D. Hooi a, A.D.M. Kester
More informationPERIPHERAL ARTERIAL DISEASE (PAD); Frequency in diabetics.
PERIPHERAL ARTERIAL DISEASE (PAD); Frequency in diabetics. ORIGINAL PROF-2084 Dr. Qaiser Mahmood, Dr. Nasreen Siddique, Dr. Affan Qaiser ABSTRACT Objectives: (1) To determine the frequency of PAD in diabetic
More informationAnkle brachial index performance among internal medicine residents
Ankle brachial index performance among internal medicine residents Vascular Medicine 15(2) 99 105 The Author(s) 2010 Reprints and permission: http://www. sagepub.co.uk/journalspermission.nav DOI: 10.1177/1358863X09356015
More informationM. Ögren,* B. Hedblad, G. Engström and L. Janzon
Eur J Vasc Endovasc Surg 29, 182 189 (2005) doi:10.1016/j.ejvs.2004.11.013, available online at http://www.sciencedirect.com on Prevalence and Prognostic Significance of Asymptomatic Peripheral Arterial
More informationORIGINAL INVESTIGATION. The Long-term Prognostic Value of the Resting and Postexercise Ankle-Brachial Index
ORIGINAL INVESTIGATION The Long-term Prognostic Value of the Resting and Postexercise Ankle-Brachial Index Harm H. H. Feringa, MD; Jeroen J. J. Bax, MD, PhD; Virginie H. van Waning, MD; Eric Boersma, PhD;
More informationEvaluation of Medical Treatment for Peripheral Arterial Disease in Chinese High-Risk Patients
Circ J 2007; 71: 95 99 Evaluation of Medical Treatment for Peripheral Arterial Disease in Chinese High-Risk Patients Buaijiaer Hasimu, MD, PhD*,, ; Jue Li, MD, PhD*; Jinming Yu, MD, PhD*; Yitong Ma, MD,
More informationPeripheral Arterial Disease, Diabetes, and Mortality
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Peripheral Arterial Disease, Diabetes, and Mortality CYNTHIA L. LEIBSON, PHD 1 JEANINE E. RANSOM, BS 1 WAYNE OLSON, BS 1
More informationPrevalence of Peripheral Arterial Disease and Risk Factors for the Low and High Ankle-Brachial Index in Chinese Patients with Type 2 Diabetes
Journal of Health Science, 52(2) 97 102 (2006) 97 Prevalence of Peripheral Arterial Disease and Risk Factors for the Low and High Ankle-Brachial Index in Chinese Patients with Type 2 Diabetes Jue Li, Buaijiaer
More informationClinical Investigation and Reports. Predictive Value of Noninvasive Measures of Atherosclerosis for Incident Myocardial Infarction
Clinical Investigation and Reports Predictive Value of Noninvasive Measures of Atherosclerosis for Incident Myocardial Infarction The Rotterdam Study Irene M. van der Meer, MD, PhD; Michiel L. Bots, MD,
More informationJOURNAL OF VASCULAR SURGERY Volume 32, Number 6 McDermott et al 1165 METHODS
Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease Mary McGrae McDermott,
More informationAnkle brachial pressure index to assess atherosclerotic risk in hypertensive subjects
International Journal of Research in Medical Sciences Salagre SB et al. Int J Res Med Sci. 2017 Feb;5(2):403-409 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20170040
More informationA: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups
A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were
More informationPrevalence, Progression and Associated Risk Factors of Asymptomatic Peripheral Arterial Disease
ORIGINAL PAPER ORIGINAL PAPER The ANNALS of AFRICAN SURGERY www.annalsofafricansurgery.com Prevalence, Progression and Associated Risk Factors of Asymptomatic Peripheral Arterial Disease Nikita Mehta 1,
More informationThank you for the opportunity to provide expert advice on the Draft Research Plan on Screening for Peripheral Artery Disease.
January 12, 2012 Robert L. Cosby, Ph.D., MSW Senior Coordinator, USPSTF Department of Health and Human Services Agency for Healthcare Research and Quality Center for Primary Care, Prevention and Clinical
More informationSupplementary Online Content
Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines
More informationCase Study: Chris Arden. Peripheral Arterial Disease
Case Study: Chris Arden Peripheral Arterial Disease Patient Presentation Diane is a 65-year-old retired school teacher She complains of left calf pain when walking 50 metres; the pain goes away after she
More informationRelationship of Ankle Blood Pressures to Cardiovascular Events in Older Adults
Relationship of Ankle Blood Pressures to Cardiovascular Events in Older Adults Kim Sutton-Tyrrell, DrPH; Lakshmi Venkitachalam, PhD; Alka M. Kanaya, MD; Robert Boudreau, PhD; Tamara Harris, MD; Trina Thompson,
More informationProgression of Peripheral Arterial Disease Predicts Cardiovascular Disease Morbidity and Mortality
Journal of the American College of Cardiology Vol. 52, No. 21, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.07.060
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More informationYOUNG ADULT MEN AND MIDDLEaged
BRIEF REPORT Favorable Cardiovascular Profile in Young Women and Long-term of Cardiovascular and All-Cause Mortality Martha L. Daviglus, MD, PhD Jeremiah Stamler, MD Amber Pirzada, MD Lijing L. Yan, PhD,
More informationUSWR 23: Outcome Measure: Non Invasive Arterial Assessment of patients with lower extremity wounds or ulcers for determination of healing potential
USWR 23: Outcome Measure: Non Invasive Arterial Assessment of patients with lower extremity wounds or ulcers for determination of healing potential MEASURE STEWARD: The US Wound Registry [Note: This measure
More informationPeripheral arterial disease (PAD) is a highly prevalent
Exertional Leg Pain in Patients With and Without Peripheral Arterial Disease Jimmy C. Wang, MD; Michael H. Criqui, MD, MPH; Julie O. Denenberg, MA; Mary M. McDermott, MD; Beatrice A. Golomb, MD, PhD; Arnost
More informationThe Ankle- Brachial Pressure Index AS A Predictor of Coronary. Artery Disease Severity
Original Article The Ankle- Brachial Pressure Index AS A Predictor of Coronary * Haider J. Al Ghizzi** Shakir M. Muhammed** MBChB, FRCP, FACC MBChB, CABM, FICMS MBChB, FICMS Fac Med Baghdad 2009; Vol.
More informationChina is the largest producer and consumer of tobacco in
Epidemiology Passive Smoking and Risk of Peripheral Arterial Disease and Ischemic Stroke in Chinese Women Who Never Smoked Yao He, MD, PhD; Tai Hing Lam, MD; Bin Jiang, MD, PhD; Jie Wang, MD, PhD; Xiaoyong
More informationABSTRACT INTRODUCTION. Use of Ankle-Brachial Index as a Predictor of Severity of Atherosclerosis
Use of Ankle-Brachial Index as a Predictor of Severity of Atherosclerosis ORIGINAL ARTICLE Use of Ankle-Brachial Index as a Predictor of Severity of Atherosclerosis in Control, High Risk Asymptomatic and
More informationNomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure
801 Original Article Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure Akira YAMASHINA, Hirofumi TOMIYAMA, Tomio ARAI, Yutaka KOJI, Minoru YAMBE, Hiroaki MOTOBE, Zydem
More informationTABLE OF CONTENTS. 2. LOWER EXTREMITY PERIPHERAL ARTERIAL DISEASE 2.1. Epidemiology Risk Factors
LOWER EXTREMITY PAD The following is one of three extracted sections lower extremity, renal/mesenteric, and abdominal aortic of the ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral
More informationAngina or intermittent claudication: which is worse?
Angina or intermittent claudication: which is worse? A comparison of self-assessed general health, mental health, quality of life and mortality in 7,403 participants in the 2003 Scottish Health Survey.
More informationCVD risk assessment using risk scores in primary and secondary prevention
CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities
More informationORIGINAL INVESTIGATION
ORIGINAL INVESTIGATION Pulse Oximetry as a Potential Screening Tool for Lower Extremity Arterial Disease in Asymptomatic Patients With Diabetes Mellitus G. Iyer Parameswaran, MD; Kathy Brand, RDMS, RVT;
More informationSelecting subjects for ultrasonographic screening for aneurysms of the abdominal aorta: four different strategies
International Epidemiological Association 1999 Printed in Great Britain International Journal of Epidemiology 1999;28:682 686 Selecting subjects for ultrasonographic screening for aneurysms of the abdominal
More informationCVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic
CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This
More informationEarly Identification of PAD: Evidence to Refute USPSTF Position on Screening
Early Identification of PAD: Evidence to Refute USPSTF Position on Screening Mehdi H. Shishehbor, DO, MPH, PhD Director Endovascular Services Interventional Cardiology & Vascular Medicine Department of
More informationWhen to screen for PAD? Prof. Dr.Tine De Backer Prof. Dr. Jean-Claude Wautrecht
When to screen for PAD? Prof. Dr.Tine De Backer Prof. Dr. Jean-Claude Wautrecht How do we define asymptomatic PAD? A. ABI < 1 B. ABI < 0.9 C. ABI < 0.8 D. ABI > 1 How do we define asymptomatic PAD? A.
More informationCigarette Smoking and Mortality in the Korean Multi-center Cancer Cohort (KMCC) Study
Journal of Preventive Medicine and Public Health March 2010, Vol. 43, No. 2, 151-158 doi: 10.3961/jpmph.2010.43.2.151 Cigarette Smoking and Mortality in the Korean Multi-center Cancer Cohort (KMCC) Study
More informationCardiovascular Diseases in CKD
1 Cardiovascular Diseases in CKD Hung-Chun Chen, MD, PhD. Kaohsiung Medical University Taiwan Society of Nephrology 1 2 High Prevalence of CVD in CKD & ESRD Foley RN et al, AJKD 1998; 32(suppl 3):S112-9
More informationPeripheral Arterial Disease in the Elderly : The Rotterdam Study
Peripheral Arterial Disease in the Elderly : The Rotterdam Study Wouter T. Meijer, Arno W. Hoes, Dominique Rutgers, Michiel L. Bots, Albert Hofman and Diederick E. Grobbee Arterioscler. Thromb. Vasc. Biol.
More informationIntensive Treatment of Diabetes is Associated with a Reduced Rate of Peripheral Arterial Calcification in Diabetes Control and Complications Trial
Diabetes Care Publish Ahead of Print, published online July 10, 2007 Intensive Treatment of Diabetes is Associated with a Reduced Rate of Peripheral Arterial Calcification in Diabetes Control and Complications
More informationThe Ankle-Brachial Index and Incident Cardiovascular Events in the MESA (Multi-Ethnic Study of Atherosclerosis)
Journal of the American College of Cardiology Vol. 56, No. 18, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2010.04.060
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationBlood Pressure Targets in Diabetes
Stockholm, 29 th August 2010 ESC Meeting Blood Pressure Targets in Diabetes Peter M Nilsson, MD, PhD Department of Clinical Sciences University Hospital, Malmö Sweden Studies on BP in DM2 ADVANCE RCT (Lancet
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More information7 th Munich Vascular Conference
7 th Munich Vascular Conference Secondary prevention of major cardiovascular events in patients with CHD or PAD - What can we learn from EUCLID and COMPASS, evaluating Clopidogrel, Ticagrelor and Univ.-Prof.
More informationNational Clinical Conference 2018 Baltimore, MD
National Clinical Conference 2018 Baltimore, MD No relevant financial relationships to disclose Wound Care Referral The patient has been maximized from a vascular standpoint. She has no other options.
More informationThe Changing Landscape of Managing Patients with PAD- Update on the Evidence and Practice of Care in Patients with Peripheral Artery Disease
Interventional Cardiology and Cath Labs The Changing Landscape of Managing Patients with PAD- Update on the Evidence and Practice of Care in Patients with Peripheral Artery Disease Manesh R. Patel MD Chief,
More informationComparison of Three Measures of the Ankle-Brachial Blood Pressure Index in a General Population
555 Original Article Hypertens Res Vol.30 (2007) No.6 p.555-561 Comparison of Three Measures of the Ankle-Brachial Blood Pressure Index in a General Population Cheng-Rui PAN 1), Jan A. STAESSEN 2), Yan
More informationVascular Medicine. Different Calculations of Ankle-Brachial Index and Their Impact on Cardiovascular Risk Prediction
Vascular Medicine Different Calculations of Ankle-Brachial Index and Their Impact on Cardiovascular Risk Prediction Christine Espinola-Klein, MD; Hans J. Rupprecht, MD; Christoph Bickel, MD; Karl Lackner,
More information290 Biomed Environ Sci, 2016; 29(4):
290 Biomed Environ Sci, 2016; 29(4): 290-294 Letter to the Editor Prevalence and Predictors of Hypertension in the Labor Force Population in China: Results from a Cross-sectional Survey in Xinjiang Uygur
More informationAntihypertensive Trial Design ALLHAT
1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes
More informationIdentification of subjects at high risk for cardiovascular disease
Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Identification of subjects at high risk for cardiovascular disease Lars Rydén Karolinska Institutet
More informationClinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease
Cronicon OPEN ACCESS EC NEUROLOGY Research Article Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Jin Ok Kim, Hyung-IL Kim, Jae Guk Kim, Hanna Choi, Sung-Yeon
More informationAssociation of low ankle brachial index with high mortality in primary care
European Heart Journal (2006) 27, 1743 1749 doi:10.1093/eurheartj/ehl092 Clinical research Vascular medicine Association of low ankle brachial index with high mortality in primary care Curt Diehm 1 *,
More informationApril 20, USPSTF Coordinator c/o USPSTF 540 Gaither Road Rockville, MD Dear Sir or Madam:
April 20, 2016 USPSTF Coordinator c/o USPSTF 540 Gaither Road Rockville, MD 20850 Dear Sir or Madam: Thank you for the opportunity to comment on the Draft Research Plan for Peripheral Artery Disease in
More informationCVD Prevention, Who to Consider
Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..
More informationMedical Decision Making
Medical Decision Making http://mdm.sagepub.com Peripheral Arterial Occlusive Disease: Prognostic Value of Signs, Symptoms, and the Ankle-Brachial Pressure Index Jurenne D. Hooi, Henri E.J.H. Stoffers,
More informationYuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China
What Can We Learn from the Observational Studies and Clinical Trials of Prehypertension? Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China At ARIC visit 4
More informationJoshua A. Beckman, MD. Brigham and Women s Hospital
Peripheral Vascular Disease: Overview, Peripheral Arterial Obstructive Disease, Carotid Artery Disease, and Renovascular Disease as a Surrogate for Coronary Artery Disease Joshua A. Beckman, MD Brigham
More informationRelationship between Arterial Stiffness and the Risk of Coronary Artery Disease in Subjects with and without Metabolic Syndrome
243 Original Article Hypertens Res Vol.30 (2007) No.3 p.243-247 Relationship between Arterial Stiffness and the Risk of Coronary Artery Disease in Subjects with and without Metabolic Syndrome Yutaka KOJI
More informationBaseline Functional Performance Predicts the Rate of Mobility Loss in Persons With Peripheral Arterial Disease
Journal of the American College of Cardiology Vol. 50, No. 10, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.05.030
More informationThe Influence of Experience on the Reproducibility of the Ankle brachial Systolic Pressure Ratio in Peripheral Arterial Occlusive Disease
Eur J Vasc Endovasc Surg 18, 25 29 (1999) Article No. ejvs.1999.0843 The Influence of Experience on the Reproducibility of the Ankle brachial Systolic Pressure Ratio in Peripheral Arterial Occlusive Disease
More informationPeripheral Arterial Disease Management A Practical Guide for Internists. EFIM Vascular Working Group
2 Peripheral Arterial Disease Management A Practical Guide for Internists EFIM Vascular Working Group 1 Peripheral arterial disease (PAD) is a growing concern among our aging population. More than 27 million
More informationInternational Journal of Basic & Applied Physiology
EARLY DIAGNOSIS OF ASYMPTOMATIC PERIPHERAL ARTERIAL DISEASE BY ANKLE- BRACHIAL PRESSURE INDEX METHOD IN SMOKERS Unmesh S Dave *, Pradnya A Gokhale **, Chinmay J Shah ***, H.B.Mehta ****, Pravin G Rabari
More informationWhat s New in the Management of Peripheral Arterial Disease
What s New in the Management of Peripheral Arterial Disease Sibu P. Saha, MD, MBA Professor of Surgery Chairman, Directors Council Gill Heart Institute University of Kentucky Lexington, KY Disclosure My
More informationValidation of a method for determination of the ankle-brachial index in the seated position
Validation of a method for determination of the ankle-brachial index in the seated position Heather L. Gornik, MD, MHS, a Bobby Garcia, BA, a Kathy Wolski, MPH, a David C. Jones, BSEE, b Kate A. Macdonald,
More informationCentral pressures and prediction of cardiovascular events in erectile dysfunction patients
Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,
More informationFelix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study
Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study Conflict of interest disclosure None Committee of Scientific Affairs Committee
More informationFatality of Future Coronary Events Is Related to Inflammation-Sensitive Plasma Proteins
Fatality of Future Coronary Events Is Related to Inflammation-Sensitive Plasma Proteins A Population-Based Prospective Cohort Study Gunnar Engström, MD; Bo Hedblad, MD; Lars Stavenow, MD; Patrik Tydén,
More informationGALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS
GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental
More informationGoals of Screening Programs. What is Vascular Screening? Assumptions Regarding the Potential Benefits of Screening Programs PAD
Conflict of Interest Disclosure (Relationships with Industry) An Epidemic of : The Debate Over Population Screening Membership on an advisory board, consultant, or recipient of a research grant from the
More informationEpidemiology and Prevention. Mortality and Vascular Morbidity in Older Adults With Asymptomatic Versus Symptomatic Peripheral Artery Disease
Epidemiology and Prevention Mortality and Vascular Morbidity in Older Adults With Asymptomatic Versus Symptomatic Peripheral Artery Disease Curt Diehm, MD, PhD; Jens Rainer Allenberg, MD, PhD; David Pittrow,
More informationJohn E. Campbell, MD. Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division
John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John Campbell, MD For the 12 months preceding this CME activity,
More informationAnkle-Arm Blood Pressure Index and Cardiovascular Risk Factors in Elderly Japanese Men
377 Original Article Ankle-Arm Blood Pressure Index and Cardiovascular Risk Factors in Elderly Japanese Men Renzhe CUI, Hiroyasu ISO, Kazumasa YAMAGISHI, Takeshi TANIGAWA, Hironori IMANO, Tetsuya OHIRA,
More informationAnkle Brachial Index as a Predictor of Coronary Artery Disease in Diabetic Patients
Original Research Article Ankle Brachial Index as a Predictor of Coronary Artery Disease in Diabetic Patients Sangeeta Pednekar 1*, Nishita Singh 2, Elizabeth James 3, Dharmendra Pandey 2 1 Professor,
More informationThe Framingham Risk Score (FRS) is widely recommended
C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score Implications for Future Risk Assessment: Results From a Large Cohort Study in Southern Germany Wolfgang Koenig, MD; Hannelore
More informationNew Guidelines in Dyslipidemia Management
The Fourth IAS-OSLA Course on Lipid Metabolism and Cardiovascular Risk Muscat, Oman, February 2018 New Guidelines in Dyslipidemia Management Dr. Khalid Al-Waili, MD, FRCPC, DABCL Senior Consultant Medical
More information1. Which one of the following patients does not need to be screened for hyperlipidemia:
Questions: 1. Which one of the following patients does not need to be screened for hyperlipidemia: a) Diabetes mellitus b) Hypertension c) Family history of premature coronary disease (first degree relatives:
More informationSubmitted: Accepted: Published online:
Neuroendocrinology Letters Volume 33 Suppl. 2 2012 O R I G I N A L A R T I C L E The Czech ABI Project Prevalence of peripheral arterial disease in patients at risk using the ankle-brachial index in general
More informationIntroduction. Risk factors of PVD 5/8/2017
PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental
More informationI n a previous article dealing with the Italian rural cohorts of
19 CARDIOVASCULAR MEDICINE Coronary risk factors predicting early and late coronary deaths A Menotti, M Lanti... See end of article for authors affiliations... Correspondence to: Dr M Lanti, Associazione
More informationwell-targeted primary prevention of cardiovascular disease: an underused high-value intervention?
well-targeted primary prevention of cardiovascular disease: an underused high-value intervention? Rod Jackson University of Auckland, New Zealand October 2015 Lancet 1999; 353: 1547-57 Findings: Contribution
More informationModule 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension
Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationProgression of asymptomatic peripheral artery disease over 1 year
1106VMJ17110.1177/1358863X11431106Vascular MedicineMohler ER III et al. Progression of asymptomatic peripheral artery disease over 1 year Vascular Medicine 17(1) 10 16 The Author(s) 2012 Reprints and permission:
More informationSerum uric acid levels improve prediction of incident Type 2 Diabetes in individuals with impaired fasting glucose: The Rancho Bernardo Study
Diabetes Care Publish Ahead of Print, published online June 9, 2009 Serum uric acid and incident DM2 Serum uric acid levels improve prediction of incident Type 2 Diabetes in individuals with impaired fasting
More informationcauses, all cancers, lung cancer and other chronic diseases in urban Shanghai.
Original Article Population attributable risks of cigarette smoking for deaths of all causes, all cancers and other chronic diseases among adults aged 40-74 years in urban Shanghai, China Ying-Ying Wang
More informationIt is well known that subjects with type. Original Research
Original Research Hellenic J Cardiol 2010; 51: 402-406 Plasma Glucose Levels and White Blood Cell Count Are Related with Ankle Brachial Index in Type 2 Diabetic Subjects At h a n a s i a Pa p a z a f i
More informationLEADER Liraglutide and cardiovascular outcomes in type 2 diabetes
LEADER Liraglutide and cardiovascular outcomes in type 2 diabetes Presented at DSBS seminar on mediation analysis August 18 th Søren Rasmussen, Novo Nordisk. LEADER CV outcome study To determine the effect
More informationAndrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University
CARDIOVASCULAR RISK FACTORS ORIGINAL ARTICLE Do We Correctly Assess the Risk of Cardiovascular Disease? Characteristics of Risk Factors for Cardiovascular Disease Depending on the Sex and Age of Patients
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More informationPeripheral arterial disease: prognostic significance and prevention of atherothrombotic complications
Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications Paul E Norman, John W Eikelboom and Graeme J Hankey Peripheral arterial disease, whether symptomatic
More informationUsing Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly
Using Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly Paul Muntner, PhD MHS Professor and Vice Chair Department of Epidemiology University of Alabama
More informationReview of guidelines for management of dyslipidemia in diabetic patients
2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University
More informationARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized
More informationWhy Do We Treat Obesity? Epidemiology
Why Do We Treat Obesity? Epidemiology Epidemiology of Obesity U.S. Epidemic 2 More than Two Thirds of US Adults Are Overweight or Obese 87.5 NHANES Data US Adults Age 2 Years (Crude Estimate) Population
More information4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for
+ Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics
More informationSubclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD
Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD Sao Paulo Medical School Sao Paolo, Brazil Subclinical atherosclerosis in CVD risk: Stratification & management Prof.
More information